Study On The Effect Of Medicated Enema And Ayurveda Oral Medicine In Management Of Medoroga (Dyslipidemia)
Phase 2
- Conditions
- Health Condition 1: E784- Other hyperlipidemia
- Registration Number
- CTRI/2019/06/019560
- Lead Sponsor
- All India Institute Of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Serum Cholesterol (201 mg/dl or more)
Serum TGLs (161 mg/dl or more)
Serum HDL (below 40 mlg/dl)
Serum LDL (131 mg/dl or more)
Serum VLDL (41 mg/dl or more) will be included in the study.
Exclusion Criteria
Systemic Disorders Like Cardiac Disease,Renal Disease, And Neurological Diseases And Who Are Not Fit For Basti Karma Will Be Excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the efficacy of Triphala kwatha administered in the schedule of Kala Basti rectal administration and oral administration of Triphala kwatha with Madhu in the management of Medoroga w.r.s to dyslipidemia. <br/ ><br> <br/ ><br>Timepoint: 3 month <br/ ><br>
- Secondary Outcome Measures
Name Time Method Overall improvement in Quality of life in Dyslipidemia. <br/ ><br>Reduction in sign and symptoms of Medoroga w.s.r. to Dyslipidemia <br/ ><br>Timepoint: 90 days